首页> 外文会议>Society for biomaterials annual meeting and exposition >Bioactivity of Amorphous Bioactive Glass and Glass-Ceramic in Simulated Body Fluid
【24h】

Bioactivity of Amorphous Bioactive Glass and Glass-Ceramic in Simulated Body Fluid

机译:模拟体液中非晶态生物活性玻璃和微晶玻璃的生物活性

获取原文

摘要

Each of the five batches tested exhibited bioactivity through hydroxyapatite formation on the surface of the samples. Porosity of the samples did not affect surface HAp formation but did have an effect on sample crystallinity. The 800℃ High porosity batch had very good hydroxyapatite formation while still having nearly a 40 MPa compressive strength after 4 weeks. This shows that the overall increased crystallinity does not have adverse effects on hydroxyapatite formation in SBF, but actually appears to increase the hydroxyapatite formation due to more bioactive crystal phases and a less weight percentage of wollastonite compared to the 900℃ High porosity batch. However, this does not suggest how the material will perform in vivo nor does it suggest how quickly the material will resorb.
机译:所测试的五批次中的每一个均通过在样品表面上形成羟基磷灰石而表现出生物活性。样品的孔隙率不会影响表面HAp的形成,但会影响样品的结晶度。 800℃高孔隙率批料具有非常好的羟基磷灰石形成,而4周后仍具有接近40 MPa的抗压强度。这表明,总体结晶度的增加不会对SBF中的羟基磷灰石形成产生不利影响,但实际上与900℃高孔隙度批次相比,由于具有更多的生物活性晶体相和重量百分比更低的硅灰石,似乎增加了羟基磷灰石的形成。但是,这并不暗示该材料在体内的表现,也不暗示该材料将吸收多快。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号